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of	 weakness,	 sensory	 alterations	 and	 pain,	 in-
creased	persistent	feelings	of	fatigue	are	reported	




and	 those	 over	 50	 but	 appears	 independent	 of	
both	the	subtype	of	GBS	and	antecedent	infec-
tion.3	Nonetheless,	severe	feelings	of	fatigue	have	
a	 considerable	 impact	 upon	 psychosocial	 and	
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those	with	severe	 fatigue	 following	GBS	had	spent	 longer	 in	hospital	 than	those	who	were	not	severely	 fatigued	
























2007.	 Only	 those	 members	 with	 a	 confirmed	
diagnosis	 of	 GBS	 were	 asked	 to	 complete	 the	
questionnaires	 and	 a	 covering	 letter	 asked	 that	
those	 with	 chronic	 inflammatory	 demyelinat-
ing	 polyneuropathy	 (CIDP)	 or	 other	 forms	 of	
peripheral	 neuropathy	 should	 not	 answer	 the	
questionnaire	as	 there	was	no	way	of	 screening	
out	 these	 members.	 The	 questionnaires	 asked	
for	general	information	(age,	gender,	time	since	
diagnosis,	 duration	 of	 inpatient	 stay,	 mobility	
on	discharge),	perceived	physical	condition	(F-
Score)	 8	 at	 worst	 and	 currently,	 current	 health	
related	quality	of	life	(Medical	Outcomes	Short	
form	36	questionnaire,	SF36),9	current	mobility,	
anxiety	 and	 depression	 (Hospital	 Anxiety	 and	
Depression	Scale,	HADS)	10	and	current	feelings	
of	fatigue	(Fatigue	Severity	Scale,	FSS).11
Once	 distributed,	 the	 investigators	 had	 no	
further	direct	contact	with	the	volunteers	but	a	
notice	was	placed	on	 the	Group’s	website	 after	










considered	 to	 demonstrate	 severe	 feelings	 of	
fatigue.12	Demographic	 and	 clinical	 character-
istics	were	then	analysed	according	to	whether	
or	 not	 the	 respondent	 reported	 severe	 fatigue.	
Categorical	 variables	 were	 summarised	 using	
numbers	 and	 percentages	 and	 compared	 by	
group	 using	 Pearson’s	 chi-square	 test.	Ordinal	
and	 interval/ratio	 variables	 were	 summarised	
using	 medians	 and	 ranges	 and	 compared	 by	
group	(severe	fatigue	or	not	severe	fatigue)	us-
ing	Mann-Whitney	 tests.	 Level	 of	mobility	 at	
discharge	and	at	the	time	of	the	survey	was	de-
termined	from	the	F-score	and	ranked	in	terms	
of	 the	 degree	 to	 which	 respondents	 required	
support	 for	 ambulation:	 walking	 independ-
ently;	using	walking	aids	[stick(s),	crutch(es)	or	







The	 association	 between	 key	 predictor	 vari-
ables	 adjusted	 for	 age	and	gender	 and	whether	
or	not	the	respondent	was	currently	severely	fa-
tigued	 was	 estimated	 using	 logistic	 regression;	
that	 between	 key	 variables	 and	 the	 FSS	 score	
was	 estimated	 using	multiple	 linear	 regression.	
All	analysis	was	undertaken	using	SPSS	Release	
15.	 Residuals	 from	 multiple	 regressions	 were	








sponses,	 703	 questionnaires	 were	 complete	 for	
the	data	of	interest	and	were	analysed	(Table	I).
Three	hundred	and	ninety	eight	(56.6%)	re-
spondents	 reported	 severe	 feelings	 of	 fatigue	
(mean	 FSS	 ≥5.0).	 These	 respondents	 had	 sig-
nificantly	 worse	 scores	 on	 all	 SF-36	 subscales,	















only	 mobility	 category	 significantly	 associated	
with	being	severely	fatigued	(OR=2.37,	95%	CI	
1.52	to	3.71,	P<0.001)	and	it	was	positively	and	
moderately	 associated	 with	 a	 higher	 FSS	 score	
(B=-0.55,	95%	CI	0.21	to	0.89,	P=0.001).	Walk-
ing	 without	 aids	 at	 discharge	 was	 significantly	






associated	 with	 being	 severely	 fatigued	 (Odds	
Ratio,	 OR=1.00,	 95%	 Confidence	 Interval,	




However,	 mobility	 at	 discharge	 from	 hospital	
was	significantly	poorer	in	respondents	who	re-






significant	 association	 between	 greater	 fatigue	
and	poorer	mobility	on	discharge	(Table	I),	the	
change	in	the	level	of	mobility	from	discharge	to	
the	 respondents’	 current	mobility	 was	 not	 sig-











Median	(range) Median	(range) P Kendall’s	taub P
Age	(years) 66	(22	to	96) 65	(19	to	87) 0.350 0.03 0.224
Time	since	diagnosis	(years) 6.3	(0.2	to	51.4) 7.2	(0.1	to	58.0) 0.361 -0.01 0.816
Duration	of	inpatient	stay	(days) 70	(2	to	820) 49	(2	to	1277) 0.003 0.08 0.005
N	(%) N	(%)
Female 206	(51.8) 149	(48.4) 0.373 0.03 0.411
Mobility	on	discharge <0.001	
Walking	without	aids 47	(12.0) 53	(17.5) 0.040	 -0.10 0.002	
Walking	with	aids 202	(51.7) 168	(55.6) 0.299 -0.01 0.677
Self-propelled/powered	wheelchair 34	(8.7) 34	(11.3) 0.261 -0.01 0.646
Pushed	in	wheelchair 102	(26.1) 36	(11.9) <0.001 0.14 <0.001	
Other 6	(1.5) 11	(3.6) 0.075 -0.07 0.022	
1	FSS	≥5,	2	FSS:	Fatigue	Severity	Scale.











Median	(range) Median	(range) p Kendall’s	taub P
HADS	3	Anxiety 8	(0	to	21) 4	(0	to	18) <0.001 0.24 <0.001
HADS	Depression 7	(0	to	21) 2	(0	to	20) <0.001 0.43 <0.001
F-score	4	at	worst 5	(1	to	6) 5	(1	to	6) 0.247 0.02 0.596













The	 findings	 demonstrated	 that	 respondents	
with	 severe	 fatigue	 had	 poorer	 health	 related	
quality	of	life.	This	finding	is	supported	by	oth-








As	 shown	 in	Table	 II,	 scores	of	 anxiety	 and	
depression	were	 still	within	or	 just	 above	nor-
mal	 levels	 in	the	current	study	10	but	respond-
ents	 with	 more	 severe	 fatigue	 demonstrated	
higher	 levels	 of	 anxiety	 and	 depression	 when	
compared	to	those	with	little	or	no	fatigue.	This	
is	 a	 novel	 finding	 as	 others	 have	 reported	 few	
differences	 in	 anxiety	 and	 depression	 between	
people	 with	 and	 without	 severe	 fatigue	 after	
GBS.7,	 17	 Furthermore,	 anti-depressant	 medi-







The	 response	 rate	 of	 the	 survey	was	moder-
ate	(58%)	and	was	similar	to	a	postal	survey	of	
fatigue	conducted	in	Norway	(60%	7).	All	mem-




naire,	 reducing	 the	 response	 rate.	As	 such,	 the	
response	rate	of	58%	should	be	considered	as	a	
conservative	 estimate.	The	 proportion	 of	 those	




This	 study	 found	 that	 severe	 fatigue	 was	
present	 in	 over	 half	 of	 all	 respondents	 (57%;	
N.=398).	This	indicates	that	fatigue	is	a	persist-
ent	symptom	of	GBS	and	agrees	with	the	find-








reported	 slightly	 lower	 levels	 of	 severe	 fatigue	
(42%	and	35%	of	24	and	29	patients	respective-
ly),	 although	 their	 samples	were	much	 smaller	












ratio 95%	CI P B 95%	CI P
Age 1.01 0.99	to	1.02 0.384 0.01 -0.002	to	0.02 0.138
Female 1.23 0.90	to	1.70 0.197 0.14 -0.12	to	0.39 0.305
Duration	of	inpatient	stay	(days) 1.00 0.99	to	1.01 0.886 0.000 -0.001	to	0.001 0.755
Walking	without	aids	at	discharge 0.74 0.46	to	1.18 0.210 -0.57 -0.96	to	-0.19 0.004	
Self-propelled/powered	wheelchair	at	discharge 0.86 0.48	to	1.55 0.620 0.09 -0.40	to	0.57 0.727
Pushed	in	wheelchair	at	discharge 2.37 1.52	to	3.71 <0.001< 0.55 0.21	to	0.89 0.001	






to	 become	more	mobile	 and	 increase	 their	 in-




longer	had	access	 to	 rehabilitation	 services	 and	






returning	 to	 some	 activities,	 some	 respondents	
could	have	undergone	cardiovascular	de-condi-
tioning.	A	reduction	 in	daily	activities	brought	




the	 severity	of	 fatigue.	Conversely,	 it	 is	 equally	















interventions.	 Further	 research	 is	 warranted	 to	
determine	if	a	greater	duration	of,	and/or	more	
intensive	 rehabilitation,	 could	 decrease	 the	 se-
verity	of	 fatigue	 in	people	who	 are	 less	mobile	
after	GBS.








ondary	 to	 greater	 feelings	 of	 fatigue.	 It	 is	 also	
possible	 that	 the	 tools	 used	 to	measure	mood	
had	items	which	could	also	represent	fatigue	or	








spondents	being	many	years	 after	 the	onset	 of	







bility	 at	 time	of	 survey:	 1,	 P<0.001)	 implying	
significant	recovery	of	impairments	and	activity	
limitations,	the	current	levels	of	fatigue	were	not	
associated	with	 this	 change.	This	finding	 indi-
cates	the	severity	of	fatigue	cannot	be	assumed	
to	change	alongside	other	symptoms	after	GBS	
and	 that	 severe	 fatigue	may	be	present	despite	
relatively	 good	 recovery	 of	 other	 impairments.	
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cipitates	 discharge	 of	 patients	 for	 whom	 little	
more	can	be	offered	other	than	continued	thera-
py	(which	can	be	conducted	in	the	community)	




could	 slow	 functional	 recovery.	 Future	 work	
could	seek	to	identify	factors	that	influence	the	








tigue	have	greater	 levels	of	 anxiety	 and	depres-
sion	and	poorer	quality	of	 life.	They	also	 show	
that	severe	fatigue	several	years	after	nadir	may	
be	 associated	with	 the	 level	 of	mobility	 at	 dis-
charge.	 However,	 whilst	 mobility	 significantly	
improved	over	time,	the	severity	of	 fatigue	was	








people	 after	GBS.	However,	 the	 results	 of	 this	














tion	 velocity	 distribution	 in	 neurologically	 well-recovered	
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